Anti‐Ribosomal P Protein Antibodies in a Japanese Patient with Systemic Sclerosis

A 56‐year‐old Japanese woman developed Raynaud's phenomenon and digital ulcerations at the age of 50. She showed rapid and diffuse skin sclerosis; visceral involvement was mild. She showed no symptoms or laboratory findings suggestive of other collagen diseases, including systemic lupus erythematosus and Sjögren's syndrome. Based on the clinical and histological findings, she was diagnosed as having diffuse cutaneous systemic sclerosis (SSc). The patient's serum produced nucleolar and cytoplasmic staining by indirect immunofluorescence analyses on HEp‐2 cell substrate and reacted with P0, P1 and P2 proteins in immunoblotting using purified ribosomal antigens. She was negative for anti‐topoisomerase I, centromere, and U1RNP antibodies. Anti‐ribosomal P protein antibodies are considered highly specific for systemic lupus erythematosus; this is the first case report of an SSc patient with anti‐ribosomal P protein antibodies. The clinical features of SSc patients with these antibodies need to be clarified by an accumulation of cases.

[1]  M. Fujimoto,et al.  Antigen specificity of antihistone antibodies in localized scleroderma. , 1994, Archives of dermatology.

[2]  D. Isenberg,et al.  Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. , 1993, British journal of rheumatology.

[3]  A. Yamada,et al.  Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. , 1992, Annals of the rheumatic diseases.

[4]  N. Brot,et al.  Antiribosomal antibodies in systemic lupus erythematosus. , 1992, Rheumatic diseases clinics of North America.

[5]  K. Takehara,et al.  Systemic lupus erythematosus associated with antiribosomal P protein antibody. , 1990, Archives of dermatology.

[6]  W. Earnshaw,et al.  Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. , 1988, Arthritis and rheumatism.

[7]  T. Medsger,et al.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. , 1988, Arthritis and rheumatism.

[8]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[9]  K. Elkon,et al.  Clinical and serologic associations of the antiribosomal P protein antibody. , 1986, Arthritis and rheumatism.

[10]  K. Elkon,et al.  Lupus autoantibodies target ribosomal P proteins , 1985, The Journal of experimental medicine.

[11]  A. Masi Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.